Emmanuel Cordero (Age: 51) | Philadelphia, PA | (310) 594-3562

Enjoy Unlimited Searches!
This secure connection is confirmed

Emmanuel Cordero (Age: 51) | Philadelphia, PA | (310) 594-3562

1 people found.

Here is a summary of the results below for the name Emmanuel Cordero (Age: 51) | Philadelphia, PA | (310) 594-3562

Data Type Total Found Additional Details
People 1 51 years of age
Email Addresses 5 Associated with Emmanuel Cordero (Age: 51) | Philadelphia, PA | (310) 594-3562
Phone Numbers 17 8 area code(s)
Area Codes 8 Including 310, 323, 562, 601 and 626
States 5 Including California, Maryland, New jersey, New york and Pennsylvania

Filter Results

Filter By:

Sort By:

Filter By State:

emmanuel cordero cordero in Philadelphia, Pennsylvania | Age - 51

Phone Number

(310) 594-3562, (973) 538-2967, (323) 661-7653

Address

Po Box 50547, Philadelphia, Pa 19132-6547

Relatives

maria contreras, abraham mejia, adrian v mejia

Email

Seen as

emmanuel c cordero

Previous Locations

Philadelphia PA, Philadelphia PA, Philadelphia PA

Employer

novartis

View Full Report

Top People with the Last Name Cordero

FAQs

Commonly asked questions about Emmanuel Cordero

How old is Emmanuel Cordero Cordero?

Emmanuel Cordero Cordero is possibly 51 years old and maybe was born in June 1974.

Where does Emmanuel Cordero Cordero live?

Emmanuel Cordero Cordero has been associated with 28 addresses, the last known one is Po Box 50547, Philadelphia, Pa 19132-6547.

What is Emmanuel Cordero Cordero’s phone number?

Emmanuel Cordero Cordero has been known to have 17 phone numbers, including (310) 594-3562.

What is Emmanuel Cordero Cordero’s email address?

Emmanuel Cordero Cordero has been known to have 27 email addresses, including mannycordero74@gmail.com.

Who is Emmanuel Cordero Cordero related to?

Emmanuel Cordero Cordero's possible relatives include Maria Contreras, Abraham Mejia, Adrian V Mejia and others.

What does Emmanuel Cordero Cordero do for a living?

Emmanuel Cordero Cordero could be a Global Trial Leader, Global Trial Management at Novartis.